AKT1 and ovarian cancer: 2015 Abstract #404; Molecular aberrations of the PI3K-AKT-mTORC1/C2 pathway in ovarian cancers: A strategy for targeted therapy, Pradip De, et al., AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference 2017, Philadelphia, PA, Abstract #462).